Daily non-political popular news in brief.
Study finds coronary procedure adds no benefit over 'optimal medical therapy' alone
03-27-2007 · EurekAlert!Percutaneous coronary intervention plus optimal medical therapy does not improve outcomes in patients with coronary artery disease, compared with optimal medical therapy alone, according to study results presented yesterday at the 56th Annual Scientific Session of the American College of Cardiology in New Orleans, and published online in the New England Journal of Medicine.
Read more »
Keywords: study, coronary, procedure, adds, benefit, optimal, medical, therapy, alone, add
« Previous | Next »
Similar news on "Study finds coronary procedure adds no benefit over 'optimal medical therapy' alone":
- Pairing medical therapy with coronary intervention fails to reduce heart disease deaths
03-26-2007 · EurekAlert!
Results of research presented today at the American College of Cardiology’s 56th Annual Scientific Session showed that percutaneous coronary interventions combined with optimal medical therapy (OMT) was no more effective than OMT alone in preventing heart attacks and other cardiac events among patients with coronary artery disease. The study will be simultaneously published in the New England Journal of Medicine and will appear in the April 12 print issue.
Similar news · Read more »
- Novel anti-oxidant and anti-inflammatory agent shows effectiveness on key endpoints in trial
03-27-2007 · EurekAlert!
Heart attacks are caused by a build-up and instability of plaque in the coronary arteries, which is often a result of chronic inflammation of the blood vessel walls. A study presented today at the American College of Cardiology's 56th Annual Scientific Session assessed whether adding a novel agent with antioxidant and anti-inflammatory properties to optimal medical therapy would reduce coronary events and death among patients with heart disease.
Similar news · Read more »
- NEJM report on cardiac emergency therapy finds single medication effective vs. combination drugs
11-22-2006 · EurekAlert!
A study published in the New England Journal of Medicine led by Columbia University Medical Center and New York-Presbyterian Hospital researchers showed that an anti-clotting agent called bivalirudin, when used by itself to treat acute coronary syndromes, reduced the risk of major bleeding, a key risk for mortality, by 47 percent compared with the standard combination drugs. The medication was found to be equally as effective as the combination of injectable blood thinners traditionally used.
Similar news · Read more »
- NIH report on intracranial stent points out need for upcoming large-scale clinical trial
02-13-2008 · EurekAlert!
A preliminary study funded by the National Institutes of Health found that a stent designed to open clogged arteries in the brain was successfully deployed in nearly all cases and significantly reduced arterial blockage in the short term. But data on the long-term benefit of the stent, compared to medical treatment alone, were inconclusive, prompting the upcoming launch of a large-scale randomized trial that is expected to provide definitive results.
Similar news · Read more »
- No benefit to mechanically opening arteries days after a heart attack
11-14-2006 · EurekAlert!
In the days following a heart attack, patients who have no or mild symptoms and undergo a procedure called angioplasty to mechanically open their totally blocked coronary arteries do not reduce their risk of having another heart attack, going into heart failure or dying, according to the results of a new study.
Similar news · Read more »
- Aspirin may be less effective heart treatment for women than men
04-27-2007 · EurekAlert!
A new study shows that aspirin therapy for coronary artery disease is four times more likely to be ineffective in women compared to men with the same medical history.
Similar news · Read more »
- Studies highlight advances in diagnosis, medical therapy
03-26-2007 · EurekAlert!
Three studies being presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit 2007 highlight the breadth of research propelling advances in clinical cardiology. One study explores the best medical and interventional treatment for patients with acute coronary syndromes, the second demonstrates the long-lasting promise of non-surgical approaches to the repair of heart valves, and the third highlights a new drug-exercise combination that improves image quality and reduces side effects.
Similar news · Read more »
- Availability may influence cancer treatment decisions
01-08-2007 · EurekAlert!
Utilization of cancer treatments with limited evidence of benefit may depend on the therapy's availability according to a new study. The study reveals that patients with pancreatic cancer were almost twice as likely to receive radiotherapy, for which there is more controversy regarding efficacy, when the treating hospital had radiotherapy available compared to patients who were treated at centers where radiotherapy was not available.
Similar news · Read more »
- Timing of start of hormone therapy may have effect on risk of coronary heart disease
04-03-2007 · EurekAlert!
Women who initiate hormone therapy closer to menopause tend to have a reduced risk of coronary heart disease compared to women who begin treatment further from menopause, but researchers did not find this reduced risk was statistically significant, according to a study in the April 4 issue of JAMA.
Similar news · Read more »
- Patients at risk of adverse events within 3 months after stopping certain ACS therapy
02-05-2008 · EurekAlert!
Patients who receive the anti-platelet medication clopidogrel following an acute coronary syndrome (such as heart attack) appear to be at greater risk of a heart attack or death in the first 90 days after stopping clopidogrel treatment, according to a study in the Feb. 6 issue of JAMA.
Similar news · Read more »
